The ConsiGma continuous tableting system from GEA Pharma Systems satisfies the pharmaceutical industry’s demand for continuous production. One ConsiGma can run 500 g in R&D, but can also run clinical trial, launch size, and any production size batches. There is no process scale-up as time is the only relevant factor in a continuous process. The system is compact and has a modular construction allowing it to fit perfectly into any R&D department or existing tablet production room. ConsiGma is capable of doing particle design and mimicking any traditional batch granulation process. The granules have generally a better intra-granular porosity with better compressibility characteristics that help tablet presses run more efficiently at maximum speed with hardly any weight adjustments being required. The full tablet production line consists of the ConsiGma granulator & dryer, combined with the Courtoy Modul P rotary tablet press. An in-line blender mixes in the external phase between the systems.